Screening small molecule fragments has
made it possible to identify pharmacological leads against otherwise hard to
target hotspots on biomolecules, such as allosteric sites, rendering this
approach a valuable alternative method of drug discovery
Roots Analysis is pleased to announce the publication of its recent study,
titled, “Fragment-based Drug Discovery Market:
Library and Service Providers, 2020-2030.”
The
report features an extensive study of the current market landscape, offering an
informed opinion on the likely adoption of this approach over the next decade.
It features an in-depth analysis, highlighting the capabilities of various
stakeholders engaged in this domain. In addition to other elements, the study
includes:
§
§
§
§
§
§
§
- Type of Technique
§
§
§
§
- Type of Service
§
§
§
- End User
§
§
- Key Geographical Region
§
§
§
Key companies covered in the report:
§ 2bind
§ Charles River Laboratories
§ ChemAxon
§ ComInnex
§ Creative Biolabs
§ Creative Biostructure
§ CRELUX
§ Domainex
§ Evotec
§ Red Glead Discover
§ SARomics Biostructures
§ Shanghai ChemPartner
§ Sygnature Discovery
§ Vernalis Research
For
more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html
Other recent offerings
1. DNA-Encoded
Libraries: Platforms and Services Market
2. Antibody
Discovery: Services and Platforms Market (2nd Edition), 2018-2028
About Roots Analysis
Roots Analysis is one
of the fastest growing market research companies, sharing fresh and independent
perspectives in the bio-pharmaceutical industry. The in-depth research,
analysis and insights are driven by an experienced leadership team which has
gained many years of significant experience in this sector. If you’d like help
with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis
Private Limited
Gaurav Chaudhary
+1 (415) 800 3415